For Metformin Add-On, No Winner in Head-to-Head CVD Trial (CME/CE)

(MedPage Today) -- Pioglitazone largely similar to sulfonylurea in pragmatic TOSCA.IT trial

For Metformin Add-On, No Winner in Head-to-Head CVD Trial (CME/CE)

(MedPage Today) -- Pioglitazone largely similar to sulfonylurea in pragmatic TOSCA.IT trial

Wed 13 Sep 17 from MedPageToday

Postprandial Glucose Drug No Help for Established Heart Disease (CME/CE)

(MedPage Today) -- Acarbose delayed diabetes onset but didn't prevent CV events

Wed 13 Sep 17 from MedPageToday

  • Pages: 1

Bookmark

Bookmark and Share